Cagrilintide Synonyms / Designations: Cagrilintide, AM833, Long-acting amylin analogue, Dual amylin receptor agonist CAS Number: 1415456-99-3 Molecular Formula: C194H312N54O59S2 Molecular Weight: 4409.01 g/mol Peptide Classification: Synthetic long-acting amylin analogue Purity: 99 % (HPLC, typical) Appearance: White to off-white lyophilised powder Pack Size: Research pack size (varies) Storage: Desiccated, protected from light, stored at 20 C Solubility: Soluble in sterile water and buffered aqueous solutions Description & Mechanism Cagrilintide is a synthetic long-acting analogue of the endogenous peptide hormone amylin, developed for experimental investigation of amylin receptor signalling and metabolic regulation
Cosmetic R&D labs use research-grade GHK-Cu as a reference compound during formulation screening, ingredient stability testing, and comparative efficacy work against alternative copper peptides or skin-active reference materials
The first and best-characterized mechanism is the AMPK pathway
This slow approach allows the body to adapt to each receptors activation, reducing gastrointestinal side effects that commonly occur with incretin medications
They clear debris, form guidance tubes called bands of Bungner, and release neurotrophic factors that signal the surviving neuron to regenerate
In the kinetic analysis, we selected a first-order kinetic model with a substrate inhibition coefficient to simulate DEHP degradation
